Status:
COMPLETED
Cost and Effectiveness of Pressurized Intraperitoneal Aerosol Chemotherapy in Patients With Peritoneal Carcinoma.
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Evaluate the Cost of a PIPAC Procedure and the Associated Hospital Stay in France
Eligibility:
All Genders
18+ years
Brief Summary
The presence of peritoneal carcinomatosis indicates a neoplastic disease evolved. Without intervention, the prognosis is poor with survival of only a few months. Standard treatment is based on systemi...
Eligibility Criteria
Inclusion
- Adult patients
- Patients treated with PIPAC and monitored for peritoneal carcinoma
- Patients informed
Exclusion
- Patients opposition
Key Trial Info
Start Date :
November 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04779385
Start Date
November 16 2020
End Date
March 30 2021
Last Update
May 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHUGA
Grenoble, France